We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSFS icon
1901
WSFS Financial
WSFS
$4.15B
$25K ﹤0.01%
515
-2,719
-84% -$134K
CBAY
1902
DELISTED
Cymabay Therapeutics
CBAY
$25K ﹤0.01%
2,671
-2,227
-45% -$19K
HALL
1903
DELISTED
Hallmark Financial Services, Inc.
HALL
$25K ﹤0.01%
233
+34
+17% +$3.78K
VRTV
1904
DELISTED
VERITIV CORPORATION
VRTV
$25K ﹤0.01%
853
-5,563
-87% -$161K
SJI
1905
DELISTED
South Jersey Industries, Inc.
SJI
$25K ﹤0.01%
790
-8,519
-92% -$282K
COHR
1906
DELISTED
Coherent Inc
COHR
$25K ﹤0.01%
+87
New +$24.2K
PKD
1907
DELISTED
Parker Drilling Company
PKD
$25K ﹤0.01%
+1,651
New +$25.5K
DF
1908
DELISTED
Dean Foods Company
DF
$25K ﹤0.01%
2,106
-4,700
-69% -$49.9K
BKHU
1909
DELISTED
Black Hills Corporation
BKHU
$25K ﹤0.01%
384
+236
+159% +$15.9K
FOGO
1910
DELISTED
Fogo de Chao, Inc. Common Stock
FOGO
$25K ﹤0.01%
2,175
-42
-2% -$485
CASC
1911
DELISTED
Cascadian Therapeutics, Inc.
CASC
$25K ﹤0.01%
6,838
-1,477
-18% -$6.05K
TRCO
1912
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$25K ﹤0.01%
589
-2,176
-79% -$89.7K
BCE icon
1913
BCE
BCE
$21.2B
$24K ﹤0.01%
515
-30,685
-98% -$1.46M
CENX icon
1914
Century Aluminum
CENX
$5.07B
$24K ﹤0.01%
1,214
-16,317
-93% -$250K
DIN icon
1915
Dine Brands
DIN
$452M
$24K ﹤0.01%
465
-1,212
-72% -$56.5K
EEMV icon
1916
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.56B
$24K ﹤0.01%
+400
New +$23.8K
GAIA icon
1917
Gaia
GAIA
$48.4M
$24K ﹤0.01%
1,943
+1,764
+985% +$21.9K
ILMN icon
1918
Illumina
ILMN
$28.4B
$24K ﹤0.01%
115
-539
-82% -$111K
LZB icon
1919
La-Z-Boy
LZB
$1.69B
$24K ﹤0.01%
770
-4,502
-85% -$130K
MFC icon
1920
Manulife Financial
MFC
$73.5B
$24K ﹤0.01%
900
-78,466
-99% -$1.63M
MFIC icon
1921
MidCap Financial Investment
MFIC
$804M
$24K ﹤0.01%
+1,390
New +$24.9K
MUR icon
1922
Murphy Oil
MUR
$4.78B
$24K ﹤0.01%
764
+641
+521% +$17.8K
NIC icon
1923
Nicolet Bankshares
NIC
$3.62B
$24K ﹤0.01%
447
-1,152
-72% -$66.4K
PTCT icon
1924
PTC Therapeutics
PTCT
$6.12B
$24K ﹤0.01%
1,413
+859
+155% +$14.5K
SANM icon
1925
Sanmina
SANM
$10.9B
$24K ﹤0.01%
729
-12,896
-95% -$450K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.